Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
APIJECT
Show more
Class 5: Syringes sold filled with pharmaceuticals, namely, pharmaceutical preparations for treating infectious diseases, diabetes, parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations and chromosomal abnorm…
Class 10: Syringes for medical purposes
Class 35: Promoting public awareness in the field of health, infectious diseases, emergency response and vaccine delivery; Promoting public awareness in the field of health, infectious diseases, emergency response and vaccine delivery by means of public advocacy
Class 5 – Pharmaceuticals & supplementsClass 10 – Medical apparatusClass 35 – Advertising & retail
Status timeline
- 21 Mar 2020Application filedNew Application Entered
- 9 Jun 2020Assigned to an examining attorneyAssigned To Examiner
- 11 Jun 2020Office action issuedNon-Final Action Written
- 10 Dec 2020Approved for publicationApproved For Pub - Principal Register
- 10 Dec 2020Response to office action filedTeas Response To Office Action Received
- 12 Jan 2021Published for oppositionPublished For Opposition
- 9 Mar 2021Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 8 Sep 2021Statement-of-use extension 1 grantedSou Extension 1 Granted
- 10 Feb 2022Statement-of-use extension 2 grantedSou Extension 2 Granted
- 25 May 2022Assigned to an examining attorneyAssigned To Examiner
- 22 Aug 2022Statement-of-use extension 3 grantedSou Extension 3 Granted
- 21 Feb 2023Assigned to an examining attorneyAssigned To Examiner
- 11 Mar 2024Statement of use filedTeas Statement Of Use Received
- 9 Apr 2024Office action issuedNon-Final Action Written
- 29 May 2024Assigned to an examining attorneyAssigned To Examiner
- 7 Jul 2024Response to office action filedTeas Response To Office Action Received
- 18 Oct 2024Statement of use acceptedAllowed Principal Register - Sou Accepted
- 3 Dec 2024Registered on the Principal RegisterRegistered-Principal Register
All 61 events
| 2025-11-06 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-11-06 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-11-06 | Teas Change Of Correspondence Received |
| 2025-01-03 | Teas Change Of Correspondence Received |
| 2024-12-03 | Registered-Principal Register |
| 2024-12-03 | Notice Of Registration Confirmation Emailed |
| 2024-10-18 | Assigned To Lie |
| 2024-10-18 | Correspondence Received In Law Office |
| 2024-10-18 | Teas/Email Correspondence Entered |
| 2024-10-18 | Allowed Principal Register - Sou Accepted |
| 2024-10-18 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2024-07-07 | Teas Response To Office Action Received |
| 2024-05-29 | Assigned To Examiner |
| 2024-04-09 | Non-Final Action Written |
| 2024-04-09 | Non-Final Action E-Mailed |
| 2024-04-09 | Notification Of Non-Final Action E-Mailed |
| 2024-03-14 | Statement Of Use Processing Complete |
| 2024-03-11 | Teas Statement Of Use Received |
| 2024-03-11 | Use Amendment Filed |
| 2023-09-08 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-09-07 | Case Assigned To Intent To Use Paralegal |
| 2023-09-07 | Sou Extension 5 Granted |
| 2023-08-28 | Sou Teas Extension Received |
| 2023-08-28 | Sou Extension 5 Filed |
| 2023-02-28 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-02-26 | Sou Teas Extension Received |
| 2023-02-26 | Sou Extension 4 Filed |
| 2023-02-26 | Sou Extension 4 Granted |
| 2023-02-21 | Assigned To Examiner |
| 2022-08-24 | Notice Of Approval Of Extension Request E-Mailed |
| 2022-08-22 | Sou Teas Extension Received |
| 2022-08-22 | Sou Extension 3 Filed |
| 2022-08-22 | Sou Extension 3 Granted |
| 2022-05-25 | Assigned To Examiner |
| 2022-02-12 | Notice Of Approval Of Extension Request E-Mailed |
| 2022-02-10 | Sou Teas Extension Received |
| 2022-02-10 | Sou Extension 2 Filed |
| 2022-02-10 | Sou Extension 2 Granted |
| 2021-09-10 | Notice Of Approval Of Extension Request E-Mailed |
| 2021-09-08 | Sou Teas Extension Received |
| 2021-09-08 | Sou Extension 1 Filed |
| 2021-09-08 | Sou Extension 1 Granted |
| 2021-08-31 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2021-08-31 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2021-08-31 | Teas Change Of Correspondence Received |
| 2021-03-09 | Noa Mailed - Sou Required From Applicant |
| 2021-01-12 | Published For Opposition |
| 2021-01-12 | Official Gazette Publication Confirmation E-Mailed |
| 2020-12-23 | Notification Of Notice Of Publication E-Mailed |
| 2020-12-10 | Examiners Amendment -Written |
| 2020-12-10 | Examiners Amendment E-Mailed |
| 2020-12-10 | Notification Of Examiners Amendment E-Mailed |
| 2020-12-10 | Examiner's Amendment Entered |
| 2020-12-10 | Approved For Pub - Principal Register |
| 2020-12-10 | Teas Response To Office Action Received |
| 2020-06-11 | Non-Final Action Written |
| 2020-06-11 | Non-Final Action E-Mailed |
| 2020-06-11 | Notification Of Non-Final Action E-Mailed |
| 2020-06-09 | Assigned To Examiner |
| 2020-03-22 | New Application Office Supplied Data Entered |
| 2020-03-21 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Syringes sold filled with pharmaceuticals, namely, pharmaceutical preparations for treating infectious diseases, diabetes, parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations and chromosomal abnorm…
First use anywhere 3 Mar 2022 · First use in commerce 5 Mar 2024
Class 10 Medical apparatus
Syringes for medical purposes
First use anywhere 3 Mar 2022 · First use in commerce 1 Jun 2023
Class 35 Advertising & retail
Promoting public awareness in the field of health, infectious diseases, emergency response and vaccine delivery; Promoting public awareness in the field of health, infectious diseases, emergency response and vaccine delivery by means of public advocacy
First use anywhere 3 Mar 2022 · First use in commerce 29 Nov 2023
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 6 Nov 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.